Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 4/25/25 → 4/25/27 |
Funding
- Janssen Research and Development LLC: $2.00
AZALEA: A Phase 3 Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
- DeFranco, Emily (PI)
- Giannone, Peter (CoI)
- Wurth, Mark (CoI)